Valneva going to see these prices again? Valneva
Short Term - We look to Sell a break of 11.58 (stop at 12.61)
A break of bespoke support at 11.80, and the move lower is already underway. Current prices have reacted from a low of 11.70, however, we expect further losses to follow. The failure to sustain the break higher and subsequent dip, formed a bearish candle and is negative for short term sentiment. Short term oscillators have turned negative.
Our profit targets will be 8.13 and 6.59
Resistance: 12.00 / 15.00 / 20.00
Support: 17.80 / 10.00 / 8.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
VLA trade ideas
Valneva is pumping hard, check it out!Valneva is developing a virus-disabled classical COVID vaccine with UK as its first client (Already 100M dosis preorder contract).
At each good news it pumps hard and then correct to the previous ATH before a new round.
By the way, be carefull as its vaccine will reach the phase I/II certification only in april. This will be a big milestone.
Valneva BullishAs is often the case when you are trading part time like me , you miss news and the initial rise after news, even if you are a trader full time you can't see what happens with everything so sometimes it's a good strategy to see a stock that has had posiitve news and let the retracement happen and buy in at that point. As we can see from the rising channel this stock looks like it is at the bottom of the retracement at the moment and about to go back up. Two strategies are available here
1. if you are a part time trader like me you would probably buy in at this point and set a stop loss for 6% or something similar.
2. if you can keep an eye on the stock or have trading software that allows some automation you would probably wait for confirmation that it is going back up (a nice green candle) and buy in at that point.
Potential upside in one month is about 20%+ , best suggestion would be to hold onto the next clinical trial news but that may be some time, I would probably play a slightly shorter game and set a sell price for 10%+
Not a professional, you are on your own